Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
7.10
+0.06 (0.85%)
At close: Jul 10, 2025, 4:00 PM
7.01
-0.09 (-1.27%)
Pre-market: Jul 11, 2025, 7:53 AM EDT
Novavax Employees
Novavax had 952 employees as of December 31, 2024. The number of employees decreased by 591 or -38.30% compared to the previous year.
Employees
952
Change (1Y)
-591
Growth (1Y)
-38.30%
Revenue / Employee
$1,318,237
Profits / Employee
$502,833
Market Cap
1.15B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
NVAX News
- 4 weeks ago - Novavax, Inc. (NVAX) Presents at Goldman Sachs 46th Annual Global Healthcare Conference Transcript - Seeking Alpha
- 4 weeks ago - Novavax's COVID-flu combo and standalone flu shots improve immunity in late-stage study - Reuters
- 4 weeks ago - Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Vaccine Candidates Showed Robust Immune Responses and Were Well Tolerated in Initial Cohort of a Phase 3 Trial - PRNewsWire
- 4 weeks ago - Vaccine actions and policy positions under US Health Secretary Kennedy - Reuters
- 4 weeks ago - Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up - Reuters
- 4 weeks ago - Why Moderna, Pfizer Stocks Are Shrugging Off RFK Jr.'s Firing of Vaccine Advisors. - Barrons
- 6 weeks ago - Novavax to Participate in Upcoming Investor Conferences - PRNewsWire
- 7 weeks ago - Novavax: Nuvaxovid FDA Approval Unlocks Several Bullish Stimuli - Seeking Alpha